أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - macrogol 3350, quantity: 13125 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

dendy pharmaceuticals pty ltd - macrogol 3350, quantity: 1 g/g - solution, powder for - excipient ingredients: - decrease/reduce/relieve constipation ; aperient/laxative ; helps reduce occurrence of constipation

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

key pharmaceuticals pty ltd - macrogol 3350, quantity: 1 g/g - powder - excipient ingredients: - for effective relief from constipation and treatment of chronic constipation. softens stools.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sodium chloride, quantity: 175.35 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6.563 g - powder, oral - excipient ingredients: acesulfame potassium; flavour - for the relief of constipation in adults. for the treatment of chronic constipation in adults and children aged 2 years and older; and the resolution and prevention of recurrence of faecal impaction (as diagnosed by a doctor) in children aged 2 years and older.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; macrogol 3350, quantity: 13.125 g - powder, oral - excipient ingredients: acesulfame potassium; flavour - for the treatment of constipation, including chronic constipation and the resolution of faecal impaction (as diagnosed by a doctor).

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; macrogol 3350, quantity: 13125 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - macrogol 3350, quantity: 13125 mg; sodium chloride, quantity: 350.7 mg; potassium chloride, quantity: 46.6 mg; sodium bicarbonate, quantity: 178.5 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium bicarbonate, quantity: 178.5 mg; macrogol 3350, quantity: 13125 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - macrogol 3350, quantity: 6562.5 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; sodium chloride, quantity: 175.35 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; macrogol 3350, quantity: 13.125 g - solution, powder for - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of chronic constipation. molaxole is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of the abdomen and rectum.